Scarica l'app Stockscreener
8.61
6.82%
-0.63
Dopo l'orario di chiusura:
8.61
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ETNB Giù?
Forum
Previsione
Precedente Chiudi:
$9.24
Aprire:
$9.36
Volume 24 ore:
1.57M
Relative Volume:
0.94
Capitalizzazione di mercato:
$1.28B
Reddito:
-
Utile/perdita netta:
$-174.61M
Rapporto P/E:
-4.3706
EPS:
-1.97
Flusso di cassa netto:
$-165.54M
1 W Prestazione:
-8.60%
1M Prestazione:
-7.82%
6M Prestazione:
+1.53%
1 anno Prestazione:
-2.16%
Intervallo 1D:
$8.455
$9.47
Intervallo di 1 settimana:
$8.455
$9.58
Portata 52W:
$4.16
$11.84
89 Bio Inc Stock (ETNB) Company Profile
Nome
89 Bio Inc
Settore
Industria
Telefono
(415) 432-9270
Indirizzo
655 MONTGOMERY STREET, SAN FRANCISCO, CA
Confronta ETNB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
8.61 | 1.36B | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-14 | Iniziato | Goldman | Neutral |
| 2025-03-13 | Iniziato | Citigroup | Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2024-04-22 | Ripresa | BofA Securities | Buy |
| 2024-01-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2023-08-28 | Iniziato | UBS | Buy |
| 2023-06-13 | Iniziato | Evercore ISI | Outperform |
| 2022-05-12 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-12-20 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-26 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-07-29 | Ripresa | BTIG Research | Buy |
| 2021-05-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-19 | Iniziato | Raymond James | Strong Buy |
| 2020-09-25 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-31 | Iniziato | Piper Sandler | Overweight |
| 2020-07-23 | Iniziato | BTIG Research | Buy |
| 2020-07-07 | Iniziato | Chardan Capital Markets | Buy |
| 2019-12-09 | Iniziato | BofA/Merrill | Neutral |
| 2019-12-09 | Iniziato | Oppenheimer | Outperform |
| 2019-12-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-12-09 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
89 Bio Inc Borsa (ETNB) Ultime notizie
Is 89bio Inc. stock overvalued or fairly pricedQuarterly Earnings Report & Free Community Consensus Stock Picks - khodrobank.com
American Century Companies Inc. Acquires 71,726 Shares of 89BIO $ETNB - Defense World
89bio Inc. stock outlook for YEARJuly 2025 Price Swings & Accurate Intraday Trading Signals - Newser
Market reaction to 89bio Inc.’s recent newsJuly 2025 Sector Moves & Reliable Entry Point Alerts - Newser
Will 89bio Inc. rebound enough to break evenWeekly Market Outlook & Expert Verified Stock Movement Alerts - Newser
Is a relief rally coming for 89bio Inc. holdersJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - Newser
89bio Inc. stock daily chart insightsQuarterly Profit Summary & Precise Buy Zone Identification - Newser
Risk adjusted return profile for 89bio Inc. analyzedJuly 2025 Big Picture & Low Drawdown Investment Ideas - Newser
What is 89bio Inc.’s valuation compared to sectorQuarterly Earnings Report & Daily Oversold Bounce Ideas - خودرو بانک
Detecting support and resistance levels for 89bio Inc.Weekly Stock Analysis & AI Optimized Trading Strategy Guides - Newser
What does recent volatility data suggest for 89bio Inc.Quarterly Profit Report & Community Verified Watchlist Alerts - Newser
Will 89bio Inc. benefit from macro trends2025 Price Action Summary & AI Driven Price Predictions - Newser
89bio Inc.’s volatility index tracking explainedJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - Newser
Evaluating 89bio Inc. with trendline analysisTrade Signal Summary & Free Safe Capital Growth Stock Tips - Newser
Leading vs lagging indicators on 89bio Inc. performance2025 Major Catalysts & Fast Gain Stock Tips - Newser
What moving averages say about 89bio Inc.July 2025 Opening Moves & Reliable Price Action Trade Plans - Newser
Using Bollinger Bands to evaluate 89bio Inc.July 2025 Drop Watch & Long Hold Capital Preservation Tips - Newser
Can 89bio Inc. stock recover from recent decline2025 Year in Review & Technical Confirmation Trade Alerts - Newser
89bio Inc. recovery potential after sell offDollar Strength & Growth Oriented Trade Recommendations - Newser
What high frequency data says about 89bio Inc.July 2025 EndofMonth & Real-Time Market Sentiment Alerts - Newser
Smart tools for monitoring 89bio Inc.’s price actionWeekly Loss Report & High Return Stock Watch Alerts - Newser
Statistical indicators supporting 89bio Inc.’s strength2025 Dividend Review & Technical Buy Zone Confirmation - Newser
Liver Disease Biotech 89bio Lines Up Triple Conference Presence: Citi, Cantor, and H.C. Wainwright - Stock Titan
Top chart patterns to watch in 89bio Inc.2025 Technical Patterns & Fast Entry Momentum Alerts - Newser
Exit strategy if you’re trapped in 89bio Inc.July 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - Newser
89 Bio Inc Azioni (ETNB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):